Tuberculosis, human immunodeficiency virus, and the immune reconstitution inflammatory syndrome
dc.contributor.author | Rapose, Alwyn | |
dc.contributor.author | Karande, S. | |
dc.date | 2022-08-11T08:09:49.000 | |
dc.date.accessioned | 2022-08-23T16:44:24Z | |
dc.date.available | 2022-08-23T16:44:24Z | |
dc.date.issued | 2017-10-11 | |
dc.date.submitted | 2018-03-14 | |
dc.identifier.citation | <p>J Postgrad Med. 2017 Oct-Dec;63(4):207-209. doi: 10.4103/jpgm.JPGM_365_17. <a href="https://doi.org/10.4103/jpgm.JPGM_365_17">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 0022-3859 (Linking) | |
dc.identifier.doi | 10.4103/jpgm.JPGM_365_17 | |
dc.identifier.pmid | 29022559 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/40492 | |
dc.description.abstract | Introduction: Tuberculosis (TB) continues to remain a major health problem in India in spite of achieving nationwide coverage with directly observed therapy since 2006. The estimated incidence of 2.2 million TB cases and a prevalence of 2.5 million in the year 2015 make India the country with the highest burden of TB in the world. In addition, it is estimated that a substantial part of the healthy population (up to 40%) has latent (inactive) TB. India had estimated 2.1 million people living with the human immunodeficiency virus (HIV) in the year 2015...HIV and TB coinfection creates a perfect storm in terms of poor outcomes secondary to the multiple challenges in the management of these two infections. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29022559&dopt=Abstract">Link to Article in PubMed</a></p> | |
dc.rights | Copyright : © 2017 Journal of Postgraduate Medicine. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | |
dc.subject | tuberculosis | |
dc.subject | HIV | |
dc.subject | India | |
dc.subject | coinfection | |
dc.subject | Bacterial Infections and Mycoses | |
dc.subject | Health Services Administration | |
dc.subject | Immune System Diseases | |
dc.subject | Immunology and Infectious Disease | |
dc.subject | Infectious Disease | |
dc.subject | International Public Health | |
dc.title | Tuberculosis, human immunodeficiency virus, and the immune reconstitution inflammatory syndrome | |
dc.type | Journal Article | |
dc.source.journaltitle | Journal of postgraduate medicine | |
dc.source.volume | 63 | |
dc.source.issue | 4 | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4308&context=oapubs&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/3297 | |
dc.identifier.contextkey | 11771547 | |
refterms.dateFOA | 2022-08-23T16:44:24Z | |
html.description.abstract | <p><p id="x-x-x-__p1">Introduction: Tuberculosis (TB) continues to remain a major health problem in India in spite of achieving nationwide coverage with directly observed therapy since 2006. The estimated incidence of 2.2 million TB cases and a prevalence of 2.5 million in the year 2015 make India the country with the highest burden of TB in the world. In addition, it is estimated that a substantial part of the healthy population (up to 40%) has latent (inactive) TB. India had estimated 2.1 million people living with the human immunodeficiency virus (HIV) in the year 2015...HIV and TB coinfection creates a perfect storm in terms of poor outcomes secondary to the multiple challenges in the management of these two infections.</p> | |
dc.identifier.submissionpath | oapubs/3297 | |
dc.contributor.department | Department of Medicine, Division of Infectious Diseases And Immunology | |
dc.source.pages | 207-209 |